ACLS Axcelis Technologies, Inc.
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force. Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.…
Industry Peers
Semiconductor Equipment & MaterialsKey Statistics
About Axcelis Technologies (NASDAQ: ACLS)
›
Axcelis Technologies (NASDAQ: ACLS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Semiconductor Equipment & Materials industry, part of the Technology sector, and reports about 1,465 employees.
The shares were at 99.94 USD on 19 November 2026, up 20.2% over 52 weeks. Its 52-week range is 73.60 USD to 193.65 USD: the price is 48.4% below the high and 35.8% above the low.
At a market capitalisation of 3.09B USD, it trades at 29.7 times trailing earnings and 16.1 times forward earnings. The median trailing P/E of its 19 largest Semiconductor Equipment & Materials peers is 35.5, a discount of 16% for ACLS.
Axcelis Technologies reports return on equity of 11.6%, an operating margin of 10.3% and revenue up 11.3% year over year.
It holds more cash than debt, a net cash position of 402.49M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 132.00 USD is 32.1% above the current price. The next earnings report is expected on 16 February 2027.